Back
Chemomab Therapeutics Ltd. 10K Form
Sell
17
CMMB
Chemomab Therapeutics Ltd.
Last Price:
$1.60
Seasonality Move:
3.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-13 | 10Q | CMMB/Chemomab Therapeutics Ltd. Quarterly |
| 2021-03-09 | 10K | CMMB/Chemomab Therapeutics Ltd. Annual |
| 2020-11-16 | 10Q | CMMB/Chemomab Therapeutics Ltd. Quarterly |
| 2020-08-14 | 10Q | CMMB/Chemomab Therapeutics Ltd. Quarterly |
| 2020-05-07 | 10Q | CMMB/Chemomab Therapeutics Ltd. Quarterly |
| 2020-03-17 | 10K | CMMB/Chemomab Therapeutics Ltd. Annual |
Receive CMMB News And Ratings
See the #1 stock for the next 7 days that we like better than CMMB
CMMB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.71 |
| Price / Book: | 0.91 |
Profitability
| EPS (TTM): | -1.46560 |
|---|---|
| Net Income (TTM): | $-9M |
| Gross Margin: | $-70.6K |
| Return on Equity: | -79.03% |
| Return on Assets: | -67.37% |
Chemomab Therapeutics Ltd. Earnings Forecast
Key Chemomab Therapeutics Ltd. Financial Ratios
-
Per Share Earnings over the last 18 years have been positive in 12 years.
Chemomab Therapeutics Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CMMB |
| Website: | chemomab.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.08 |
| Quick Ratio: | 7.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CMMB Technical Analysis vs Fundamental Analysis
Sell
17
Chemomab Therapeutics Ltd. (CMMB)
is a Sell
Is Chemomab Therapeutics Ltd. a Buy or a Sell?
-
Chemomab Therapeutics Ltd. stock is rated a SellThe current Chemomab Therapeutics Ltd. [CMMB] share price is $1.56. The Score for CMMB is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.